News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Matthias Ocker: Novel small molecule MCL-1 inhibitor in vivo clearance and robust efficacy in solid and hematological tumor models
Photo from Matthias Ocker/X
Aug 31, 2024, 18:32

Matthias Ocker: Novel small molecule MCL-1 inhibitor in vivo clearance and robust efficacy in solid and hematological tumor models

Matthias Ocker, Head of Experimental Medicine at Tacalyx GmbH, shared on X:

“I’m excited to share our recent publication on a novel small molecule MCL-1 inhibitor now out in Nature Cancer. Thanks to an outstanding team to accomplish this.”

solid and hematological tumor

BRD-810 is a highly selective MCL1 inhibitor with optimized in vivo clearance and robust efficacy in solid and hematological tumor models

Authors: Ulrike Rauh, Guo Wei, Michael Serrano-Wu, Georgios Kosmidis, Stefan Kaulfuss, Franziska Siegel, Kai Thede, James McFarland, Christopher T. Lemke, Nicolas Werbeck, Katrin Nowak-Reppel, Sabine Pilari, Stephan Menz, Matthias Ocker, Weiqun Zhang, Kyle Davis, Guillaume Poncet-Montange, Jennifer Roth, Douglas Daniels, Virendar K. Kaushik, Brian Hubbard, Karl Ziegelbauer, Todd R. Golub

solid and hematological tumor

Source: Matthias Ocker/X

Brian Hubbard cancer Christopher T. Lemke Douglas Daniels Franziska Siegel Georgios Kosmidis Guillaume Poncet-Montange Guo Wei James McFarland Jennifer Roth Kai Thede Karl Ziegelbauer Katrin Nowak-Reppel Kyle Davis Matthias Ocker Michael Serrano-Wu Nature Cancer Nicolas Werbeck OncoDaily Oncology Sabine Pilari solid and hematological tumors Stefan Kaulfuss Stephan Menz Todd R Golub Ulrike Rauh Virendar K. Kaushik Weiqun Zhang
Special Coverage
Blog
Dec 21, 2024, 14:10
Arif Kamal: Ensuring all people have access to the cancer navigation services that will help them live more and better days
Blog
Dec 21, 2024, 14:06
The Accelerate 2025 Annual Conference Agenda Is Here!
Blog
Dec 21, 2024, 14:03
Pioneer the future of discovery and innovation with a fully funded Bicentenary PhD Studentship at The University of Manchester
Blog
Dec 21, 2024, 14:00
NCI Division of Cancer Prevention - DHT Derived Biomarkers and COAs for Remote Monitoring and Endpoint Development
Blog
Dec 21, 2024, 13:51
The ESMO President Letter emphasises the importance of collective action to shape the future of oncology
Blog
Dec 21, 2024, 13:48
Overcoming recurrence: How research is bringing new hope for breast cancer patients - The Institute of Cancer Research
Blog
Dec 21, 2024, 13:46
IARC - Cancer Incidence in Five Continents, Vol XII
Blog
Dec 21, 2024, 13:43
National University Cancer Institute, Singapore clinicians had the exciting opportunity to present their work at the ESMO Asia 2024
Blog
Dec 21, 2024, 13:40
UICC - Welcoming the newest member, The World Hepatitis Alliance
Blog
Dec 21, 2024, 13:35
Pediatric Cancer and Blood Disorders Center of Armenia - Prioritizing the continuous education and knowledge exchange of the medical staff
Blog
Dec 21, 2024, 13:33
SIOP Europe - International Childhood Cancer Day 2025
Blog
Dec 21, 2024, 13:29
Canadian Cancer Society - How 5 organizations are working to take on cancer’s biggest issues